
Johnson & Johnson Highlights Multiple Blood Cancer Trial Data At ASCO Presentation
Johnson & Johnson JNJ shared data from several cancer studies at the 2025 American Society of Clinical Oncology (ASCO) annual meeting on Tuesday. Here’s that the New Brunswick, New Jersey-based company released. Phase 3 AMPLITUDE Study Johnson & …